NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

AIDS Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



HIV/AIDS Co-Infection



Studies from D. Pinna and co-researchers in the area of HIV/AIDS co-infection published



November 3rd, 2008

"Herpes simplex virus type 1 (HSV-1) and HSV-2 are neurotropic viruses and common human pathogens causing major public health problems such as genital herpes, a sexually transmitted disease also correlated with increased transmission and replication of human immunodeficiency virus type 1 (HIV-1). Therefore, compounds capable of blocking HIV-1, HSV-1, and HSV-2 transmission represent candidate microbicides with a potential added value over that of molecules acting selectively against either infection," researchers in Milan, Italy report.

"We report here that sulfated derivatives of the Escherichia coli K5 polysaccharide, structurally highly similar to heparin and...


Source: AIDS Weekly (2008-11-03)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login